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SUMMARY 
Haemoglobinopathies are common in sub-Saharan Africa. As such haemoglobin electrophoresis are required to in-
form clinical decision making. However, haemoglobin electrophoresis is an assay that detects protein at either alka-
line or acidic pH. Such assays do not interrogate gene sequences but rather the product of a gene. As many post-
transcriptional and post-translational modifications impact the final output of the gene (i.e. protein), presentation of 
such protein-based assay must accurately reflect the technique employed. It is grossly misleading and scientifically 
inaccurate to report cellulose acetate and/or citrate agar haemoglobin electrophoresis results as ‘haemoglobin geno-
type’. We propose a new paradigm in which haemoglobin electrophoresis data would be presented as ‘haemoglobin 
phenotype’ at a specified pH.   
 
Funding: None declared 
 




Many scientific literature reporting on various haemo-
globin (Hb) electrophoresis assays present the results as 
“Hb genotype” as could be evidenced in some sampled 
publications.1-3 However, from the scientific viewpoint, 
this reportage is grossly misleading and must be cor-
rected as it leads to lots of misunderstanding in clinical 
practice. As explained elsewhere and also illustrated in 
Figure 1, protein expression is a series of events: gene 
that encodes messenger RNA production; mRNA splic-
ing; protein synthesis; post-translational modification of 
protein and protein folding into native/functional mole-
cule.4 Techniques that probe any aspect of this protein 
expression process must report its findings to reflect 
exactly what was measured to inform appropriate inter-
pretation and clinical utility.  
 
Haemoglobin electrophoresis 
Hb electrophoresis is a technique that detects the pres-
ence of native protein and is thus far removed from the 
gene that encoded its synthesis. Although the technique 
is very useful, there is need for clarity as to what exactly 
the technique measures and what it does not.  
This would help in defining the appropriate terminolo-
gies/nomenclature that is consistent with the electropho-
retic technique and curtail any propensity to over-stretch 
the interpretation of its results beyond its intended use. 
Haemoglobin is composed of two molecules: haem and 
globin. The genes coding for globin chain synthesis are 
inherited on chromosome 11 (β-gene cluster) and chro-
mosome 16 (α-gene cluster).5-6  
 
Inadequate or lack of globin chain synthesis (i.e. thalas-
saemias), and/or mutations that leads to production of 
abnormal structural globin chain synthesis (e.g. Hb S, C, 
D variants) collectively leads to the clinical conditions 
referred to as haemoglobinopathies.6 Within limits, Hb 
electrophoresis technique is a protein assay able to de-
tect the presence of abnormal structural globin variants 
such as Hb S, C, D, as well as normal variants like Hb F 
and Hb A2.5 
 
However, the technique is generally silent on the thalas-
saemias. Taken together, in an individual co-inheriting 
an abnormal structural globin chain and defective globin 
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For example, HbS/α-thalassaemia, HbC/β-thalassaemia, 
haemoglobin electrophoresis would estimate the S and 
C respectively but not directly on the α- and β-
thalassaemias. Thus, such results could at best be pre-
sented as “Hb phenotype” to accurately reflect that the 
assay measured a protein. Only assays that employ pol-
ymerase chain reaction (PCR) or various gene sequenc-
ing platforms that interrogate the genes expressed on 
chromosomes should present such data as genotypes as 
these accurately deals with gene level assay (see Figure 
1). 
 
Figure 1 Schematic presentation of gene expression 
from mRNA to protein synthesis. Genes encode for 
mRNA production in the nucleus (transcription). Protein 
synthesis occurs on ribosomes in the cytoplasm (transla-
tion). Various techniques that may be used to assess 
each step of gene expression are listed under each stage 
with the subsequent outputs. PCR= polymerase chain 
reaction, RT-PCR= reverse transcriptase PCR, FISH= 
fluorescence in situ hybridization, ELISA= enzyme-




In spite of the obvious limitations inherent in the Hb 
electrophoresis assay, some authors choose to report 
their data as “Hb genotype”. For example, in alka-
line/cellulose acetate electrophoresis (pH 8.2 – 8.6) (5, 
7): 
1. Haemoglobins A2, C, E and O co-migrate to the same 
spot. 
2. Haemoglobins S, D and G co-migrate to the same 
spot. 
 
Thus, as illustrated in figure 2, the detection of haemo-
globin bands at the Hb A2 and S regions (after a cellu-
lose acetate paper electrophoresis) does not necessarily 
mean the sample has only Hb A2 and S; such individual 
could as well have Hb S and C, or Hb D and C.  
Additionally, the presence of only a single band in the S 
region (after cellulose acetate paper electrophoresis) 
also does not necessarily indicate that the individual is 
‘Hb SS genotype’ (see Figure 1A).  
 
Additionally, the Hb electrophoresis assay does not 
generally predict inheritance of thalassaemia. As shown 
in Figure 2B, employing both cellulose acetate and cit-
rate agar electrophoresis in analyzing the same sample 
has the advantage of a greater coverage. However, this 
is not the case in clinical practice in our hospital set-
tings; even in cases where both techniques are em-
ployed, they still deal with proteins.  
 
Figure 2 A typical electrophoretic mobility pattern at 
two separate pHs. Figure A is a cellulose acetate elec-
trophoresis read-out; note that haemoglobins A2, C, E 
and O co-migrate whereas haemoglobins S, D, and G 
also co-migrate at alkaline pH. Figure B is a citrate agar 
electrophoresis plate (pH=6.0); note that haemoglobins 
A, D, E and G co-migrate at this pH. 
 
Moreover, many issues of disputed parentage arise in 
cases where the implicated child might have inherited a 
compound defect comprising a globin chain synthesis 
defect (e.g. thalassaemia intermedia) and a structural 
haemoglobin defect (e.g. Hb S or C). Ensuring that the 
Hb electrophoresis assay data is accurately presented 
becomes crucial in such instances as spousal integrity 
and/or parental responsibilities would be at stake.  
 
Thus, the scientific community owes the public the debt 
of ensuring that data presented in the literature and/or 
laboratory report form is a reflection of the strengths as 
well as the limitations of the technique employed to 
remove all causes of misunderstanding in the public 
domain. This is not only ethically required but a moral 
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Evidently, the various gene assay platforms (see figure 
1) offers lots of leverage with regards to understanding 
the pathophysiology of disease processes. These are 
able to determine the exact mutation, and/or chromoso-
mal aberrations that may underlie a particular disease 
process.8 It is also able to detect single nucleotide poly-
morphisms (SNPs) that may modulate the pathology of 
certain diseases as well as differences in responses to 
the same drug therapy.9  
 
As these advanced techniques are being used to map 
diseases and subsequently tailor treatment to the exact 
needs of individual patients elsewhere10, developing 
countries should do well to invest capital in these tech-
nologies so as to tap into the enormous potential of the-
se state of the art technologies.  
 
CONCLUSION 
Presentation of any data as ‘genotype’ must be reserved 
for data emanating from such platforms as PCR or DNA 
microarray. We propose a new paradigm in which hae-
moglobin electrophoresis data would be presented as 
‘haemoglobin phenotype’ at a specified pH. 
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